CX 2026 Registration

CX 2026 – The 48th Charing Cross Symposium

The Charing Cross (CX) Symposium continues to set the standard in vascular and endovascular education, shaping the future of practice worldwide. CX 2026 marked the final chapter of our current three-year cycle, designed to spark debate on the biggest controversies in the field. Our distinguished faculty of global experts critically examined the evidence, exchanged perspectives, and worked towards building consensus on the issues that matter most.

Consensus was the defining theme for CX 2026. We welcomed an international community of specialists, educators, and innovators to tackle the pressing challenges in vascular and endovascular medicine—challenges that directly impact patient outcomes and clinical decision-making.

In 2024, CX found a new home at ExCeL London, unlocking fresh opportunities for immersive, hands-on learning. The expanded workshop programme has gone from strength to strength, offering delegates practical skills alongside groundbreaking evidence and innovation. In 2026, we returned once again to London’s premier conference and exhibition venue to deliver an agenda packed with cutting-edge science, expert debate, and future-shaping education.

Stay connected—sign up for the CX Newsletter and be the first to hear the latest updates.

CX Co-Chairs

Dittmar Böckler
Dittmar BöcklerHeidelberg, Germany
Andrew Holden
Andrew HoldenAuckland, New Zealand
Erin Murphy
Erin MurphyCharlotte, United States

Latest CX news

CX 2017: Peripheral Arterial Consensus highlights

March 22nd, 2017|Comments Off on CX 2017: Peripheral Arterial Consensus highlights

The CX 2017 Peripheral Arterial Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up. "Over three days (25–27 April) there will be [...]

CX 2017: Acute Stroke Consensus highlights

March 15th, 2017|Comments Off on CX 2017: Acute Stroke Consensus highlights

Interventions in the aorta and manipulations in the aortic arch have become a “potential source of embolisation to the brain,” notes Roger Greenhalgh, Chairman of the CX Programme Organising Board. The Acute Stroke Consensus [...]

What makes CX so special?

March 10th, 2017|Comments Off on What makes CX so special?

Vascular and endovascular thought-leaders Andrew Holden, Thomas Zeller, Stephen Black, Ian Franklin, Nicholas Inston, Matt Thompson and Giovanni Torsello share their views on what makes CX so special. What makes CX so special for [...]